A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease
PHASE3CompletedINTERVENTIONAL
Enrollment
194
Participants
Timeline
Start Date
Not specified
Primary Completion Date
March 31, 2001
Study Completion Date
March 31, 2001
Conditions
Lyme Disease
Interventions
DRUG
ceftriaxone
DRUG
doxycycline
Trial Locations (1)
02111
Mark Klempner, Boston
All Listed Sponsors
lead
National Institute of Allergy and Infectious Diseases (NIAID)
NIH
NCT00001101 - A Randomized, Double-Blind, Placebo-Controlled, Multicenter Trial of the Safety and Efficacy of Ceftriaxone and Doxycycline in the Treatment of Patients With Seropositive Chronic Lyme Disease | Biotech Hunter | Biotech Hunter